Yahoo Finance • 4 months ago
DUBLIN, August 14, 2024--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organisation, today announced the appointment of Nigel Clerkin as its new Chief Financial Officer (CFO). Nige... Full story
Yahoo Finance • 8 months ago
Highlights Net business wins in the quarter of $2,654 million; a net book to bill of 1.27, an increase of 9.9% on quarter one 2023. Closing backlog of $23.4 billion, an increase of 2.5% on quarter four 2023 and 10.1% on quarter one 2023.... Full story
Yahoo Finance • 11 months ago
ICON (NASDAQ:ICLR) has had a great run on the share market with its stock up by a significant 13% over the last three months. As most would know, fundamentals are what usually guide market price movements over the long-term, so we decided... Full story
Yahoo Finance • 11 months ago
DUBLIN, January 24, 2024--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced results from a recent industry survey of over 100 professionals engaged... Full story
Yahoo Finance • 12 months ago
DUBLIN, January 04, 2024--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organization, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the 42nd Annual J.P. Mo... Full story
Yahoo Finance • last year
Healthcare intelligence organisation earns recognition as employer of choice and leading innovator in the clinical trial industry DUBLIN, December 18, 2023--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence... Full story
Yahoo Finance • 2 years ago
DUBLIN, March 29, 2023--(BUSINESS WIRE)--ICON plc(NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the first quarter 2023 after the ma... Full story
Yahoo Finance • 2 years ago
According to the National Center for Advancing Translational Sciences, the average period from therapy discovery to Food and Drug Administration (FDA) approval is 14 years and costs $1 billion. Clinical research organizations (CROs) and co... Full story
Yahoo Finance • 2 years ago
ICON (NASDAQ:ICLR) Full Year 2022 Results Key Financial Results Revenue: US$7.74b (up 41% from FY 2021). Net income: US$505.3m (up 230% from FY 2021). Profit margin: 6.5% (up from 2.8% in FY 2021). The increase in margin was driven by hi... Full story
Yahoo Finance • 2 years ago
Highlights Net business wins in the quarter of $2,350 million; a net book to bill of 1.20. Full year net business wins of $9,450 million; a net book to bill of 1.22. Closing backlog in the quarter of $20.7 billion, an increase of 2.4% on... Full story
Yahoo Finance • 2 years ago
In this article, we discuss 10 Jim Cramer stocks to watch in August. If you want to see more of Jim Cramer’s latest stock picks, click 5 Jim Cramer Stocks to Watch in August. Mad Money’s Jim Cramer told investors on July 28 to use their h... Full story
Yahoo Finance • 3 years ago
Baron Funds, an asset management firm, published its “Baron Health Care Fund” first quarter 2022 investor letter – a copy of which can be downloaded here. In the quarter ended March 31, 2022, Baron Health Care Fund (the “Fund”) declined 9.... Full story